Drug shows promise for triple-negative breast cancer
Tulane scientists, led by Dr. Bridgette Collins-Burow, have reported research results of a promising new therapy for triple-negative breast cancer. (Photo by Paula Burch-Celentano)
(Medical Xpress) -- A promising new therapy for hard-to-treat triple-negative breast cancer has been reported in the journal Breast Cancer Research by a team at the Tulane University School of Medicine, led by Dr. Bridgette Collins-Burow.
More than one million cases of breast cancer are diagnosed worldwide every year, of which approximately 15 percent are triple-negative cancers, according to the team that reported on the study.
“Lack of effective therapies, young age at the onset of the disease and early metastatic spread have contributed to the poor prognoses and outcomes associated with these malignancies,” says Collins-Burow, an assistant professor of medicine.
Some kinds of breast cancer can be treated with drugs that target hormone receptors, which are protein structures on and inside cells. In healthy cells and most kinds of cancer cells, hormones attach to such receptors and provide signals to the cells for growth and functioning.
These cancers can be treated by hormonal therapies — drugs that bind to the receptors in place of hormones, thus cutting off hormonal signaling and eventually killing the cells.
But triple-negative breast cancers lack these hormone receptors, so the cancer cells continue to flourish. Triple-negative cancers also lack the growth factor receptor HER2 and cannot be treated with monoclonal therapy such as Herceptin.
The Tulane team explored the effect of using a histone deacetylase (HDAC) inhibitor called panobinostat on triple-negative breast cancer tumors in mice. This drug inhibits the actions of rogue enzymes that are responsible for allowing the uncontrolled growth of cancer cells.
“Panobinostat selectively targeted triple-negative breast cancer cells and decreased tumor growth in mice,” says Collins-Burow. “It was also able to partially reverse the morphological changes in cells to a more epithelial type. These results show a potential therapeutic role for HDAC inhibitors, especially panobinostat, in targeting the aggressive triple-negative breast cancer.”
More information: breast-cancer-rese… ent/14/3/R79
Journal reference:
Breast Cancer Research
Provided by
Tulane University
-
Blocking DNA: HDAC inhibitor targets triple negative breast cancer
May 21, 2012 |
not rated yet |
0
-
Breaking the backbone of triple-negative breast cancers
Mar 19, 2012 |
not rated yet |
0
-
Five-year U.K. breast cancer trial starts
Jan 16, 2008 |
not rated yet |
0
-
Novel technique switches triple-negative breast cancer cells to hormone-receptor positive cells
Nov 01, 2011 |
not rated yet |
0
-
Trio of drugs may combat 'triple negative' breast cancer
Dec 10, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
How can there be a term called "intestinal metaplasia" of stomach
16 hours ago
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Small cancer risk following CT scans in childhood and adolescence confirmed
The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...
Cancer
5 hours ago |
not rated yet |
0
Changing cancer's environment to halt its spread
By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...
Cancer
6 hours ago |
not rated yet |
0
Novel RNA-based classification system for colorectal cancer
A novel transcriptome-based classification of colon cancer that improves the current disease stratification based on clinicopathological variables and common DNA markers is presented in a study published in PLOS Medicine this w ...
Cancer
6 hours ago |
not rated yet |
0
Low radiation scans help identify cancer in earliest stages
A study of veterans at high risk for developing lung cancer shows that low-dose computed tomography (LDCT) can be highly effective in helping clinicians spot tiny lung nodules which, in a small number of patients, may indicate ...
Cancer
8 hours ago |
not rated yet |
0
Poliovirus vaccine trial shows early promise for recurrent glioblastoma
An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.
Cancer
10 hours ago |
not rated yet |
0
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.